Women in Ophthalmology Summer Symposium

Women in Ophthalmology Summer Symposium

Source:

Hipsley A, et al. Multi-center clinical trial results of laser scleral microporation in presbyopic eyes. Presented at: Women in Ophthalmology Summer Symposium; Aug. 21-23, 2020 (virtual meeting).

Disclosures: The study authors report they receive personal fees from Ace Vision Group.
August 26, 2020
1 min read
Save

Laser scleral microporation may restore visual performance in presbyopic eyes

Source:

Hipsley A, et al. Multi-center clinical trial results of laser scleral microporation in presbyopic eyes. Presented at: Women in Ophthalmology Summer Symposium; Aug. 21-23, 2020 (virtual meeting).

Disclosures: The study authors report they receive personal fees from Ace Vision Group.
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Patients with presbyopia treated with laser scleral microporation experienced up to a three times increase in their binocular visual field, according to a poster at the virtual Women in Ophthalmology Summer Symposium.

“Laser scleral microporation is an ultra-minimally invasive procedure to restore visual function in presbyopic patients by using a near-infrared laser to uncross-link aged scleral tissue and decrease biomechanical stiffness in the eye,” poster co-author AnnMarie Hipsley, DPT, PhD, told Healio/OSN.

Hipsley and colleagues evaluated changes in visual outcomes of 32 presbyopic eyes of 16 patients who underwent laser scleral microporation (Ace Vision Group) performed with an Er:YAG laser. The laser creates a microporation in four quadrants of a 5 mm by 5 mm matrix in five anatomic zones, which uncross-links aged scleral microfibrils over the area of the ciliary muscles, Hipsley said.

Ann Marie Hipsley
AnnMarie Hipsley

Patients gained a mean logMAR visual acuity of 0.21 at near and intermediate at 3 months. In the early results of five patients, the average area of binocular summation increased to 104.68 mm2 from 70.45 mm2 at baseline. Some patients experienced up to a three times increase in their binocular visual field at 1 month.

Preliminary results of the technology show it to be a safe and effective procedure for restoring all ranges of vision, according to the poster.

“Whereas extended depth of focus aims to impact a patient’s depth of focus through an IOL replacement of a cataract patient’s natural lens, [laser scleral microporation] therapy restores dynamic clear vision to the presbyopic patient by impacting all optical elements to restore visual functionality without replacing it,” Hipsley told Healio/OSN.